Recent Advances in the Epidemiology, Screening, and Management of Hepatitis C Virus Infection in Pregnancy

Abstract: Hepatitis C virus (HCV) affects an estimated 58 million people worldwide, with rising rates among women of reproductive age. This trend has important implications in […]

Practice Tips From the Updated Helicobacter pylori Treatment Guidelines

Abstract: In 2024, the American College of Gastroenterology released updated guidelines for managing Helicobacter pylori infection, replacing the previous 2017 guidelines. Since that time, 3 new […]

Redefining Early Intervention and the Window of Opportunity in Crohn’s Disease

Abstract: Crohn’s disease is a chronic, progressive inflammatory bowel condition characterized by unpredictable episodes of flare and remission. Inflammation that is not controlled, and even in […]

Diagnostic and Management Approach to Reflux-Related Cough

Abstract: Chronic cough, defined as cough persisting longer than 8 weeks, affects approximately 10% of the global population and significantly impairs quality of life. Gastroesophageal reflux […]

Systematic Approach to Treatment of Chronic Pancreatitis

Abstract: Chronic pancreatitis (CP) is a progressive fibroinflammatory disease of the pancreas with complex pathogenesis and diverse etiologies. CP can lead to numerous complications, including pain, exocrine […]

Remote Patient Monitoring and Connected Technologies in Inflammatory Bowel Disease

Abstract: Remote patient monitoring (RPM) has emerged as a valuable complement to traditional in-person clinical assessments, particularly since the COVID-19 pandemic. RPM encompasses a wide range […]

Evolution of Advanced Combination Treatment in Inflammatory Bowel Disease

Abstract: Despite multiple new advanced therapeutic options for the treatment of inflammatory bowel disease (IBD), almost half of patients do not achieve clinical remission and the […]

Primary Biliary Cholangitis: Novel and Emerging Therapies

Abstract: Primary biliary cholangitis (PBC) is a slowly progressive autoimmune liver disease that, if not promptly and appropriately treated, can lead to significant morbidity, mortality, and […]

Understanding Inflammatory Bowel Disease in Women From Puberty to Menopause

Abstract: Women with inflammatory bowel disease (IBD) experience distinct physiologic and clinical challenges across their lifespan. In childhood and adolescence, early exposure to corticosteroids, chronic inflammation, […]

Precision Medicine in Disorders of Gut-Brain Interaction

Abstract: Overarching goals for the practice of medicine include preventing disease, making the correct diagnosis, and initiating evidence-based therapy to improve patient symptoms and quality of […]

Pan-Gut Dysmotility in Parkinson Disease

Abstract: Parkinson disease (PD) is a rapidly growing neurologic disorder affecting millions of people worldwide. While bradykinesia, rigidity, and tremor define its motor phenotype, gastrointestinal (GI) […]

Natural Products for the Treatment of Irritable Bowel Syndrome

Abstract: Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction that significantly impacts quality of life. Studies indicate that more than one-third of patients […]

Use of Terlipressin in Liver Transplant Candidates

Abstract: The use of terlipressin in the treatment of hepatorenal syndrome type 1 (HRS-1) in patients with advanced cirrhosis wait-listed for liver transplant (LT) has been […]

Eosinophils Beyond the Esophagus: A Review of Non-EoE Eosinophilic Gastrointestinal Diseases

Abstract: For eosinophilic esophagitis (EoE), the most well researched of the eosinophilic gastrointestinal diseases (EGIDs), there is a plethora of knowledge for its diagnosis and management; […]

Update on Organ Allocation and Liver Transplantation

Abstract: Liver transplantation remains a lifesaving intervention for patients with end-stage liver disease; however, organ demand continues to far exceed the supply. The core ethical principles […]

Irritable Bowel Syndrome in Inflammatory Bowel Disease Patients: Prevalence, Etiology, and Treatment

Abstract: One in 4 patients with endoscopically confirmed quiescent inflammatory bowel disease (IBD) reports persistent gastrointestinal symptoms, which are often compatible with irritable bowel syndrome (IBS). […]

New Approaches to Screening for Barrett Esophagus

Abstract: Current screening methods for Barrett esophagus (BE), the precursor to esophageal adenocarcinoma (EAC), are inadequate with less than one-third of screen-eligible patients currently undergoing screening. […]

From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis

Abstract: Within the evolving landscape of eosinophilic esophagitis (EoE) management are multiple pharmacologic treatment modalities, including proton pump inhibitors (PPIs), swallowed topical corticosteroids, and novel biologic […]

Looking Toward the Future: Emerging Therapies for Hepatocellular Carcinoma

Abstract: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide. Despite the decreasing prevalence of hepatitis C, the burden of HCC is expected to […]

Enhancing the Diagnostic Yield of EGD for Diagnosis of Barrett Esophagus Through Methylated DNA Biomarker Triage

Abstract: Background: EsoGuard (EG) is a methylated DNA assay for cells collected nonendoscopically with EsoCheck for detection of Barrett esophagus (BE) and can be utilized as […]